News Conference News ESC Heart Failure 2025 HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM Todd Neale May 19, 2025
News Conference News ESC 2024 HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM L.A. McKeown August 30, 2024
News Conference News ESC 2023 More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM Michael O'Riordan August 31, 2023
News Conference News ESC Heart Failure 2023 Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial Shelley Wood May 23, 2023
News Conference News AHA 2022 CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis Yael L. Maxwell November 05, 2022
News Conference News AHA, Editors, and Cardiologists Ask: How Did ‘Racist’ Paper Make It to Print? Michael O'Riordan August 05, 2020